SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000357097-17-000013
Filing Date
2017-01-27
Accepted
2017-01-27 08:01:23
Documents
6
Period of Report
2017-03-01
Effectiveness Date
2017-01-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A fcscdef14a012717.htm DEF 14A 269931
2 fcsccolorlogo.jpg GRAPHIC 74382
3 maslowskisignature.jpg GRAPHIC 8295
4 proxycardsm2017finalpg1.jpg GRAPHIC 474090
5 proxycardsm2017finalpg2.jpg GRAPHIC 295336
6 proxycoverphoto2016.jpg GRAPHIC 1612888
  Complete submission text file 0000357097-17-000013.txt   3664202
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31564 | Film No.: 17551622
SIC: 2834 Pharmaceutical Preparations